創傷治療用生物製剤の世界市場レポート 2025年

創傷治療用生物製剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.2％で29億6,000万米ドルに成長します。予測期間の成長は、個別化医療への注目、ヘルスケア支出の増加、価値ベースのヘルスケアモデル、先端治療への需要の高まり、規制当局の支援と承認に起因します。予測期間における主な動向としては、再生医療の重視、バイオエンジニアリングによる代用皮膚、革新的な送達システム、慢性創傷管理の増加、患者中心のケアなどが挙げられます。

糖尿病の有病率の増加が、近い将来の創傷治療用生物製剤市場の成長を牽引すると予想されます。糖尿病は血糖値の上昇を特徴とする慢性的な代謝疾患であり、時間の経過とともに心臓、血管、目、腎臓、神経に深刻なダメージを与える可能性があります。生物学的創傷ケア製品は、過剰な水分損失、熱損失、タンパク質や電解質の損失を防ぐと同時に、汚染を最小限に抑えます。自己溶解性剥離を促進し、顆粒状の創傷層の形成を促進します。糖尿病の有病率の高さは、創傷治療用生物製剤市場の成長に寄与する重要な要因です。例えば、2024年6月、英国の政府部門である国民保健サービス（NHS）は、40歳未満の糖尿病患者の増加を報告し、2022年の173,166人から2023年には216,440人に増加しました。この著しい増加は、この年齢層における厄介な傾向を示しており、若年層における糖尿病有病率の急速な上昇を浮き彫りにしています。このように、糖尿病有病率の高さが創傷治療用生物製剤市場の拡大を牽引しています。

外科手術の増加により、創傷治療用生物製剤市場の今後の成長が期待されます。外科的処置には、患者の病状を治療するために切開や器具の使用を必要とする医療介入が含まれます。創傷治療用生物製剤には通常、自然治癒プロセスを促進する生きた細胞、成長因子、その他の生物学的材料が含まれています。外科手術の件数が増えるにつれて、手術創の治癒を早め、合併症を減らし、患者の転帰全体を改善する高度な創傷ケアソリューションへの関心も高まっています。例えば、フランスを拠点とする政府間組織である経済協力開発機構は2023年10月、チェコ共和国における白内障手術件数が8.4％増加し、2022年の手術件数は142,670件で、2021年の131,612件から増加すると報告しています。このように、手術件数の増加が創傷治療用生物製剤市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界創傷治療用生物製剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の創傷治療用生物製剤市場：成長率分析
• 世界の創傷治療用生物製剤市場の実績：規模と成長, 2019-2024
• 世界の創傷治療用生物製剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界創傷治療用生物製剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の創傷治療用生物製剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物学的皮膚代替品
• 外用剤
• 世界の創傷治療用生物製剤市場傷の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 潰瘍
• 外科手術
• 外傷
• バーンズ
• 世界の創傷治療用生物製剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター（ACS）
• 火傷センター
• 創傷クリニック
• 世界の創傷治療用生物製剤市場、生物学的皮膚代替品の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 無細胞真皮マトリックス
• 細胞性皮膚代替品
• 複合皮膚代替品
• 世界の創傷治療用生物製剤市場、局所薬剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 成長因子
• 抗菌剤
• 酵素デブリードマン剤

第7章 地域別・国別分析

• 世界の創傷治療用生物製剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の創傷治療用生物製剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 創傷治療用生物製剤市場：競合情勢
• 創傷治療用生物製剤市場：企業プロファイル
  • Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Organogenesis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Smith and Nephew plc Overview, Products and Services, Strategy and Financial Analysis
  • Wright Medical Group NV Overview, Products and Services, Strategy and Financial Analysis
  • MiMedx Group Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Kerecis AG
• Amnio Technology LLC
• Anika Therapeutics Inc.
• ACell Inc.
• Derma Sciences Inc.
• Soluble Systems Pvt. Ltd.
• Medline Industries LP
• Solsys Medical LLC
• Zimmer Biomet Holdings Inc.
• MLM Biologics Inc.
• Tissue Genesis LLC
• Stryker Corporation
• Marine Polymer Technologies Inc.
• Bioventus Inc.
• Molnlycke Health Care AB

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 創傷治療用生物製剤市場2029：新たな機会を提供する国
• 創傷治療用生物製剤市場2029：新たな機会を提供するセグメント
• 創傷治療用生物製剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Wound care biologics refer to bioengineered products specifically designed for the treatment of non-healing wounds in the lower extremity. These biologics are gaining prominence in wound care due to their effective control of secretions and protective properties against bacterial infections.

The primary products within the field of wound care biologics include biologic skin substitutes and topical agents. Biologic skin substitutes play a crucial role in wound healing and have proven to be highly beneficial within the medical industry. Also known as tissue-engineered products or artificial skin, biologic skin substitutes are biological substances that facilitate wound healing by promoting the generation of new tissues. Wound care biologics are commonly utilized to treat various types of wounds, including ulcers, surgical wounds, traumatic wounds, and burns. The end users of these biologics include hospitals, Ambulatory Surgical Centers (ASCs), burn centers, and wound clinics.

The wound care biologics software market research report is one of a series of new reports from The Business Research Company that provides wound care biologics software market statistics, including wound care biologics software industry global market size, regional shares, competitors with a wound care biologics software market share, detailed wound care biologics software market segments, market trends and opportunities, and any further data you may need to thrive in the wound care biologics software industry. This wound care biologics software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wound care biologics market size has grown strongly in recent years. It will grow from$1.91 billion in 2024 to $2.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to clinical evidence and studies, regulatory framework development, wound care market evolution, limited treatment options, research and development efforts

The wound care biologics market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to focus on personalized medicine, rise in healthcare expenditure, value-based healthcare models, growing demand for advanced therapies, regulatory support and approvals. Major trends in the forecast period include regenerative medicine emphasis, bioengineered skin substitutes, innovative delivery systems, rise in chronic wound management, patient-centric care.

The increasing prevalence of diabetes is expected to drive the growth of the wound care biologics market in the near future. Diabetes is a chronic metabolic condition characterized by elevated blood glucose levels, which can lead to severe damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Biological wound care products help prevent excessive water loss, heat loss, and the loss of proteins and electrolytes, while also minimizing contamination. They facilitate autolytic debridement and promote the formation of a granular wound layer. The high prevalence of diabetes is a key factor contributing to the growth of the wound care biologics market. For instance, in June 2024, the National Health Service (NHS), a UK-based government department, reported an increase in diabetes cases among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth indicates a troubling trend in this age group and highlights the rapid rise in diabetes prevalence among younger populations. Thus, the high prevalence of diabetes is driving the expansion of the wound care biologics market.

The rising number of surgical procedures is expected to drive the growth of the wound care biologics market in the future. Surgical procedures involve medical interventions that require incisions or the use of instruments to treat a patient's medical condition. Wound care biologics typically include living cells, growth factors, or other biological materials that promote the natural healing process. As the volume of surgical procedures increases, so does the interest in advanced wound care solutions that can expedite the healing of surgical wounds, reduce complications, and improve overall patient outcomes. For example, in October 2023, the Organization for Economic Co-operation and Development, a France-based intergovernmental organization, reported an 8.4% increase in cataract surgeries in the Czech Republic, with a total of 142,670 procedures in 2022, up from 131,612 in 2021. Thus, the increase in surgical procedures is fueling the growth of the wound care biologics market.

Major companies in the wound care biologics market are concentrating on developing advanced materials, such as bioengineered, electrospun synthetic polymer matrices, to improve wound healing efficacy and support tissue regeneration. These bioengineered matrices facilitate faster wound healing and enhanced tissue regeneration by acting as scaffolds that encourage cellular migration and growth. For example, in October 2024, Royal Biologics, a US-based orthobiologics and life sciences company, introduced two innovative products at the symposium on advanced wound care: the Peak Powder Collagen Matrix, which enhances healing in various wounds by creating a gel-like barrier that supports tissue regeneration, and ElectroFiber 3D, a bioengineered matrix that promotes cellular migration and reduces healing times. These advancements significantly influence the wound care biologics market by addressing the increasing demand for effective healing solutions.

Skin graft development is a major focus for key companies in the wound care biologics market, aiming to gain a competitive edge. Skin grafting involves a surgical procedure where healthy skin is transplanted from one body area (donor site) to another area that has lost its protective covering due to injury, surgery, burns, or other traumatic conditions. For instance, in July 2022, Tides Medical, a US-based biotechnology company, launched Artacent AC, a tri-layer skin graft designed for treating complex or challenging wounds. With a three-layer structure (amnion-chorion-amnion), it surpasses traditional dual-layer products, being three times stronger and two times thicker. Artacent AC is developed to enhance handling and application to wound sites, offering clinicians an improved solution for complex patient wounds in various medical conditions such as diabetic foot ulcers, chronic wounds, burns, Mohs surgery, and other surgical applications. The product boasts a longer shelf life at room temperature, eliminating the need for refrigeration, and can be placed on either side facing the wound.

In July 2023, Coloplast, a US-based healthcare company, acquired Kerecis for $1.3 billion. Through this acquisition, Coloplast aims to strengthen its presence in the advanced wound care market by integrating Kerecis's innovative fish skin technology. This move helps Coloplast enter the high-growth U.S. biologics sector, enhance its revenue and gross margins, and raise its long-term organic growth guidance from 7% to 9% to 8% to 10%, all while allowing Kerecis to operate as a standalone business unit. Kerecis is an Iceland-based company specializing in regenerative medicine solutions using fish skin to treat chronic wounds and surgical applications.

Major companies operating in the wound care biologics market include Integra Lifesciences Corporation, Organogenesis Inc., Smith and Nephew plc, Wright Medical Group NV, MiMedx Group Inc., Kerecis AG, Amnio Technology LLC, Anika Therapeutics Inc., ACell Inc., Derma Sciences Inc., Soluble Systems Pvt. Ltd., Medline Industries LP, Solsys Medical LLC, Zimmer Biomet Holdings Inc., MLM Biologics Inc., Tissue Genesis LLC, Stryker Corporation, Marine Polymer Technologies Inc., Bioventus Inc., Molnlycke Health Care AB, Lynch Biologics LLC, Skye Biologics Holdings LLC, Osiris Therapeutics Inc., Vericel Corporation, TissueTech Inc., PolarityTE Inc., Avita Medical Limited, Celularity Inc., Human Regenerative Technologies LLC, PolyRemedy Inc.

North America was the largest region in the wound care biologics market in 2024. Asia-pacific is expected to be the fastest-growing region in the global wound care biologics market report during the forecast period. The regions covered in the wound care biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the wound care biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The wound care biologics market consists of revenues earned by entities by providing wound care services such as surgical and traumatic wounds, burns chronic wounds and acute Wounds. The market value includes the value of related goods sold by the service provider or included within the service offering. The wound care biologics market also includes sales of surgical equipment's, medical tape, sponges, cotton pads which are used in providing wound care biologics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wound Care Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wound care biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wound care biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wound care biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Biologic Skin Substitutes; Topical Agents
• 2) By Wound Type: Ulcers; Surgical; Traumatic Wounds; Burns
• 3) By End User: Hospitals; Ambulatory Surgery Center (ACS); Burn Centers; Wound Clinics
• Subsegments:
• 1) By Biologic Skin Substitutes: Acellular Dermal Matrices; Cellular Skin Substitutes; Composite Skin Substitutes
• 2) By Topical Agents: Growth Factors; Antimicrobial Agents; Enzymatic Debridement Agents
• Companies Mentioned: Integra Lifesciences Corporation; Organogenesis Inc.; Smith and Nephew plc; Wright Medical Group NV; MiMedx Group Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wound Care Biologics Market Characteristics

3. Wound Care Biologics Market Trends And Strategies

4. Wound Care Biologics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Wound Care Biologics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Wound Care Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Wound Care Biologics Market Growth Rate Analysis
• 5.4. Global Wound Care Biologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Wound Care Biologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Wound Care Biologics Total Addressable Market (TAM)

6. Wound Care Biologics Market Segmentation

• 6.1. Global Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologic Skin Substitutes
• Topical Agents
• 6.2. Global Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ulcers
• Surgical
• Traumatic Wounds
• Burns
• 6.3. Global Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgery Center (ACS)
• Burn Centers
• Wound Clinics
• 6.4. Global Wound Care Biologics Market, Sub-Segmentation Of Biologic Skin Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acellular Dermal Matrices
• Cellular Skin Substitutes
• Composite Skin Substitutes
• 6.5. Global Wound Care Biologics Market, Sub-Segmentation Of Topical Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Growth Factors
• Antimicrobial Agents
• Enzymatic Debridement Agents

7. Wound Care Biologics Market Regional And Country Analysis

• 7.1. Global Wound Care Biologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Wound Care Biologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wound Care Biologics Market

• 8.1. Asia-Pacific Wound Care Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wound Care Biologics Market

• 9.1. China Wound Care Biologics Market Overview
• 9.2. China Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wound Care Biologics Market

• 10.1. India Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wound Care Biologics Market

• 11.1. Japan Wound Care Biologics Market Overview
• 11.2. Japan Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wound Care Biologics Market

• 12.1. Australia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wound Care Biologics Market

• 13.1. Indonesia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wound Care Biologics Market

• 14.1. South Korea Wound Care Biologics Market Overview
• 14.2. South Korea Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wound Care Biologics Market

• 15.1. Western Europe Wound Care Biologics Market Overview
• 15.2. Western Europe Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wound Care Biologics Market

• 16.1. UK Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wound Care Biologics Market

• 17.1. Germany Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wound Care Biologics Market

• 18.1. France Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wound Care Biologics Market

• 19.1. Italy Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wound Care Biologics Market

• 20.1. Spain Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wound Care Biologics Market

• 21.1. Eastern Europe Wound Care Biologics Market Overview
• 21.2. Eastern Europe Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wound Care Biologics Market

• 22.1. Russia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wound Care Biologics Market

• 23.1. North America Wound Care Biologics Market Overview
• 23.2. North America Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wound Care Biologics Market

• 24.1. USA Wound Care Biologics Market Overview
• 24.2. USA Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wound Care Biologics Market

• 25.1. Canada Wound Care Biologics Market Overview
• 25.2. Canada Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wound Care Biologics Market

• 26.1. South America Wound Care Biologics Market Overview
• 26.2. South America Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wound Care Biologics Market

• 27.1. Brazil Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wound Care Biologics Market

• 28.1. Middle East Wound Care Biologics Market Overview
• 28.2. Middle East Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wound Care Biologics Market

• 29.1. Africa Wound Care Biologics Market Overview
• 29.2. Africa Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wound Care Biologics Market Competitive Landscape And Company Profiles

• 30.1. Wound Care Biologics Market Competitive Landscape
• 30.2. Wound Care Biologics Market Company Profiles
  • 30.2.1. Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Organogenesis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Smith and Nephew plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Wright Medical Group NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. MiMedx Group Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Wound Care Biologics Market Other Major And Innovative Companies

• 31.1. Kerecis AG
• 31.2. Amnio Technology LLC
• 31.3. Anika Therapeutics Inc.
• 31.4. ACell Inc.
• 31.5. Derma Sciences Inc.
• 31.6. Soluble Systems Pvt. Ltd.
• 31.7. Medline Industries LP
• 31.8. Solsys Medical LLC
• 31.9. Zimmer Biomet Holdings Inc.
• 31.10. MLM Biologics Inc.
• 31.11. Tissue Genesis LLC
• 31.12. Stryker Corporation
• 31.13. Marine Polymer Technologies Inc.
• 31.14. Bioventus Inc.
• 31.15. Molnlycke Health Care AB

32. Global Wound Care Biologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wound Care Biologics Market

34. Recent Developments In The Wound Care Biologics Market

35. Wound Care Biologics Market High Potential Countries, Segments and Strategies

• 35.1 Wound Care Biologics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Wound Care Biologics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Wound Care Biologics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer